10-Q: Greenlight Re Q3 Net Loss Amid Investment Downturn

Greenlight Capital Re reports a Q3 net loss of $4.4 million and a significant drop in year-to-date net income, primarily due to adverse investment performance, despite strong underwriting gains.

Summary

• Reported a net loss of $4.4 million for the three months ended September 30, 2025, a significant decline from a net income of $35.2 million in the prior year's comparable quarter.
• Year-to-date (YTD) net income decreased to $25.6 million in 2025 from $70.2 million in 2024.
• Diluted EPS was $(0.13) for Q3 2025 and $0.74 for YTD 2025, down from $1.01 and $2.02 respectively in the prior year periods.
• Gross premiums written increased by 9.5% to $184.4 million in Q3 2025 and by 9.5% to $611.9 million YTD 2025.
• Net underwriting income significantly improved to $22.3 million in Q3 2025 (from $6.1 million in Q3 2024) and to $22.6 million YTD 2025 (from $9.8 million YTD 2024).
• The combined ratio improved by 9.3 percentage points to 86.6% in Q3 2025 and by 2.5 percentage points to 95.4% YTD 2025.
• Investment in related party fund Solasglas reported a net loss of 3.2% in Q3 2025 and 0.4% YTD 2025, contrasting with gains of 5.2% and 11.9% in the prior year periods.
• The Innovations investment portfolio incurred an $11.9 million loss in Q3 2025, primarily due to a $16.4 million impairment charge.
• Fully diluted book value per share increased by 5.3% to $18.90 at September 30, 2025, from $17.95 at December 31, 2024.
• Total debt decreased by $26.0 million to $34.7 million, with term loans refinanced into a $50 million revolving credit facility.

Sentiment

Score: 4

Explanation: While underwriting performance showed significant improvement, the substantial losses from the investment portfolio, particularly Solasglas and Innovations, led to a net loss for the quarter and a sharp decline in year-to-date net income, indicating overall weaker financial results.

Positives

• Net underwriting income showed strong improvement, reaching $22.3 million in Q3 2025 compared to $6.1 million in Q3 2024.
• The consolidated combined ratio improved significantly by 9.3 percentage points to 86.6% in Q3 2025, driven by a lower attritional loss ratio and no CAT losses.
• The current year loss ratio improved by 11.9 percentage points in Q3 2025 and 3.5 percentage points YTD 2025.
• No CAT event losses were incurred in Q3 2025, compared to $12.1 million in Q3 2024.
• Gross premiums written increased by 9.5% in Q3 2025 and YTD 2025, indicating business growth.
• Fully diluted book value per share increased by 5.3% to $18.90 since December 31, 2024.
• Total debt decreased by $26.0 million, and the company refinanced its term loans with a more flexible $50 million revolving credit facility.
• Estimated Probable Maximum Loss (PML) for a single event and aggregate decreased slightly from July 1, 2025, to October 1, 2025.

Negatives

• Reported a net loss of $4.4 million for Q3 2025, a substantial decrease from $35.2 million net income in Q3 2024.
• Year-to-date net income significantly declined to $25.6 million in 2025 from $70.2 million in 2024.
• Investment in Solasglas, the related party investment fund, generated a net loss of 3.2% in Q3 2025 and 0.4% YTD 2025, a sharp contrast to prior year gains.
• The Innovations investment portfolio incurred an $11.9 million loss in Q3 2025, including a $16.4 million impairment charge on private investments.
• Foreign exchange resulted in a $2.0 million loss in Q3 2025 due to the weakening of the pound sterling against the U.S. dollar.
• Prior year adverse reserve development of $0.8 million in Q3 2025 and $8.1 million YTD 2025, primarily in the Open Market segment due to casualty and financial lines.
• Increased competition in the Open Market segment is putting pressure on headline rates.

Risks

• Any suspension or revocation of the company's licenses.
• Losses from catastrophes and other major events.
• A downgrade or withdrawal of A.M. Best ratings.
• The loss of significant brokers.
• The performance of Solasglas Investments, LP.
• The carrying values of investments made under the Greenlight Re Innovations segment may differ significantly from fair value.
• Uncertain global economic outlook and persistent inflationary trends.
• Potential impact of relevant economic factors on the underwriting portfolio.
• DME Advisors believes the equity markets are very expensive.
• U.S. Administration trade policies causing additional uncertainty and volatility.
• Concentration of credit risk with financial institutions and retrocessionaires.
• Outcomes of legal disputes may ultimately differ, potentially materially, from current estimates.
• Valuations of the potential impact of movements in interest rates, equity securities prices, and foreign currency exchange rates.
• Commodity price risk related to Solasglas' long or short investments in commodities like gold, copper, and uranium.

Future Outlook

The company anticipates continued increased competition in the reinsurance market, particularly in the Open Market segment, which may pressure headline rates. Management is focused on maintaining a diversified portfolio resilient to market pressures. The global economic outlook remains uncertain, with inflationary trends expected to persist, and the company is monitoring potential impacts on its underwriting portfolio. DME Advisors maintains a conservative investment position, viewing equity markets as expensive, and is vigilant regarding U.S. trade policies and their economic implications.

Management Comments

• "We continue to see increased competition from existing and new reinsurance markets, predominantly in our Open Market segment. This is putting pressure on headline rates across various classes; however, attachment points and other terms & conditions are largely holding firm."
• "Our focus remains on maintaining a diversified portfolio that is resilient to market supply-demand pressures."
• "There are many factors contributing to an uncertain global economic outlook, and in particular, we believe that inflationary trends of recent years could persist. We continue to consider the potential impact of relevant economic factors on our underwriting portfolio."
• "On the investment side, DME Advisors regularly monitors and re-positions Solasglas investment portfolio to manage the impact of inflation on its underlying investments and holds macro positions to benefit from a rising inflationary environment. DME Advisors remains conservatively positioned as it believes the equity markets are very expensive."
• "During 2025, the U.S. Administration enacted trade policies that were more aggressive than the financial markets expected, causing additional uncertainty and volatility. These policies continue to complicate the near-term outlook for economic growth and inflation. We remain vigilant to economic data and additional policies that may impact our business."

Industry Context

The reinsurance industry is experiencing heightened competition, particularly in the Open Market segment, leading to pressure on headline rates. However, key terms and conditions, such as attachment points, are largely stable. The broader economic environment is characterized by an uncertain global outlook and persistent inflationary trends, which the company is actively monitoring for impacts on its underwriting and investment strategies. The investment manager's view that equity markets are expensive aligns with a cautious stance in a volatile economic climate, further complicated by aggressive U.S. trade policies.

Legal Proceedings

• Involved in formal and informal dispute resolution procedures in the ordinary course of business.
• Does not believe any existing dispute will have a material adverse effect on the business, financial condition, or operating results.

Related Party Transactions

• Investment Advisory Agreement with Solasglas Investments, LP, involving management fees and performance allocation.
• David Einhorn, Chairman of Greenlight Capital Re, also serves as Chairman of Green Brick Partners, Inc. (GRBK), in which Solasglas and DME Advisors affiliates collectively own 23.7% of common shares.
• Service agreement with DME Advisors for investor relations services, compensated at $5,000 per month plus expenses.
• Collateral Assets Investment Management Agreement with DME Advisors for managing certain collateral assets, with no fees received by DME Advisors.

Stakeholder Impact

• Shareholders experienced a net loss for the quarter and a significant reduction in YTD net income, potentially impacting investor confidence, despite an increase in book value per share.
• Employees benefit from active share-based compensation plans, providing incentives.
• Customers (Cedents) benefit from improved underwriting performance, but adverse prior year reserve development in some segments could be a concern.
• Creditors see reduced debt and an amended credit agreement for greater flexibility, indicating stable creditworthiness.
• Investment Partners (Solasglas, Innovations) are directly impacted by the negative investment performance and impairment charges.

Next Steps

• Evaluate the disclosure impact of recently issued accounting standards (ASU 2023-09 and ASU 2024-03).
• DME Advisors will continue to monitor and reposition the Solasglas investment portfolio.
• The company will remain vigilant to economic data and additional policies that may impact its business.
• The share repurchase plan, authorizing up to $25.0 million, is active until June 30, 2026.
• Service Restricted Stock Units (RSUs) will vest evenly over three years on January 1.
• Performance Restricted Stock Units (RSUs) will cliff vest at the end of a three-year performance period.

Key Dates

Recommendation

The company's core underwriting business demonstrated strong performance and improved efficiency, as evidenced by the significantly better combined ratio and net underwriting income. However, this positive operational performance was overshadowed by substantial losses from the investment portfolio, particularly Solasglas and the Innovations segment, leading to a net loss for the quarter and a sharp decline in year-to-date net income. Given the mixed results and the uncertain economic and competitive outlook, a 'hold' recommendation is appropriate. Investors should monitor for a turnaround in investment performance to justify a more bullish stance, while the underlying underwriting strength prevents a 'sell' recommendation.

Keywords

Reinsurance, Property and Casualty, SEC Filing, 10-Q, Financial Results, Underwriting, Investments, Solasglas, Innovations, CAT Losses, Combined Ratio, Book Value, Debt Refinancing, Share Repurchase, Risk Management, Corporate Governance, GLRE